Scott Gottlieb, MD, Discover and Read the Best of Twitter Threads by @ScottGottliebMD

Scott Gottlieb, MD

ScottGottliebMD

Tech transfers take a long time even in collaborations, and even longer when third parties are trying to copy a process de novo. We must pursue real public health solutions

It is deeply unfortunate that we head into Fall without enough doses of this drug. Many of us were talking about this as early as March. Regeneron did extraordinary work

THREAD: The standards FDA is reportedly considering for a covid vaccine EUA represent appropriate balance between speed and safety in a crisis. Even under EUA; you want higher assurance of

THREAD: For the last 6 months, FDA’s device center worked effectively with labs to advance hundreds of tests for Covid. A new HHS policy that extricates FDA from this work

By the time Covid became epidemic in the U.S. this year, and the shelter in place orders were first implemented, influenza season had all but resolved in America. This fall,

THREAD: This is a hard moment - but it’s a brief moment in our long history. It’s six months until we get to a technology to end the Covid epidemic

When we see data showing in hospital mortality for Covid patients aged 35-44 of almost 5% we should keep in mind — that’s exceptionally high; especially since criteria for admission

Thread: States reporting recent uptick in covid hospitalizations 1/2 Additional states reporting uptick. (Note: only about 60% of states report covid hospitalizations). 2/2

Important finding. It suggests that herd immunity could be achieved at a lower threshold than what's typically assumed, because the most susceptible people are the ones who get infected first.

THREAD: We're not out of the woods in U.S. on #covid. While there are signs of slowing in some areas, and nationally we may have hit a plateau, we're still

THREAD: There's risk a second wave of #COVID19 in Fall 2020 will coincide with flu season; and surging covid infections will confound ability to ramp testing, make full use of

Doctors should be aware most serology tests haven't been reviewed by FDA. Quality is highly variable, with some or perhaps many giving uncertain results. False positive rates may be inappropriately